<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>String Manipulation</title>


<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>


<style type="text/css">
  code {
    white-space: pre;
  }
  .sourceCode {
    overflow: visible;
  }
</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(data-line-number);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">String Manipulation</h1>



<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" data-line-number="1"><span class="kw">library</span>(chariot)</a></code></pre></div>
<p>This data is a sample of the names of clinical studies form ClinicalTrials.gov.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" data-line-number="1">sample_strings &lt;-</a>
<a class="sourceLine" id="cb2-2" data-line-number="2">tibble<span class="op">::</span><span class="kw">tribble</span>(</a>
<a class="sourceLine" id="cb2-3" data-line-number="3">        <span class="op">~</span>official_title,</a>
<a class="sourceLine" id="cb2-4" data-line-number="4">                        <span class="st">&quot;Clinical Performance of Existing Wearers of Avaira Sphere (Enfilcon A) Following a Refit With Clariti Elite Sphere (Somofilcon A) Lenses for 4 Weeks&quot;</span>,</a>
<a class="sourceLine" id="cb2-5" data-line-number="5">                        <span class="st">&quot;An Open-label Exploratory Phase II Study of the Safety and Immunogenicity of Repeated 'rhC1INH' Administration of 50 U/Kg in Patients With Hereditary C1 Inhibitor Deficiency ('HAE')&quot;</span>,</a>
<a class="sourceLine" id="cb2-6" data-line-number="6">                        <span class="st">&quot;Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a Pilot&quot;</span>,</a>
<a class="sourceLine" id="cb2-7" data-line-number="7">                        <span class="st">&quot;The Role of Fractional CO2 Laser in Consolidation Treatment of Recurrent Vulvovaginal Candidiasis (RVVC) ï¼ša Study Protocol for a Randomized Controlled Trial&quot;</span>,</a>
<a class="sourceLine" id="cb2-8" data-line-number="8">                        <span class="st">&quot;Colonization, Safety, Tolerance, and Effects of Three Probiotic Strains on the Immune System of Healthy Adults&quot;</span>,</a>
<a class="sourceLine" id="cb2-9" data-line-number="9">                        <span class="st">&quot;The Reduction of Microalbuminuria in Japanese Hypertensive Subjects With Type 2 Diabetes Mellitus Treated With Valsartan or Amlodipine: Study Design for the Shiga Microalbuminuria Reduction Trial (SMART)&quot;</span>,</a>
<a class="sourceLine" id="cb2-10" data-line-number="10">                        <span class="st">&quot;A Randomized Open-Label Non-Inferiority Study to Examine the Impact of Pertussis Vaccination of Healthcare Workers on Post-exposure Prophylaxis&quot;</span>,</a>
<a class="sourceLine" id="cb2-11" data-line-number="11">                        <span class="st">&quot;Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing&quot;</span>,</a>
<a class="sourceLine" id="cb2-12" data-line-number="12">                        <span class="st">&quot;Prophylactic Sub-lay Non-absorbable Mesh Following Emergent Midline Laparotomy Clean/Contaminated Field: Early Results of a Randomized Double-blind Prospective Trial: PROMETHEUS&quot;</span>,</a>
<a class="sourceLine" id="cb2-13" data-line-number="13">                        <span class="st">&quot;A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-06252616 In Healthy Subjects&quot;</span>,</a>
<a class="sourceLine" id="cb2-14" data-line-number="14">                        <span class="st">&quot;Patient Benefit From the New Modular Shoulder Prosthesis PROMOS - a Multicentre Cohort Study&quot;</span>,</a>
<a class="sourceLine" id="cb2-15" data-line-number="15">                        <span class="st">&quot;Hospital-based Home Care for Children With Cancer&quot;</span>,</a>
<a class="sourceLine" id="cb2-16" data-line-number="16">                        <span class="st">&quot;Serum Levels of Advanced Glycation End-products After Dietary Intervention in Hypertensive Patients: Study Protocol of a Randomized Clinical Trial.&quot;</span>,</a>
<a class="sourceLine" id="cb2-17" data-line-number="17">                        <span class="st">&quot;The Effect of Blood Flow Restriction Training on Muscle Atrophy Following Knee Surgery; A Randomized Control Trial&quot;</span>,</a>
<a class="sourceLine" id="cb2-18" data-line-number="18">                        <span class="st">&quot;OtimizaÃ§Ã£o do Sistema de SaÃºde no Brasil Com Telemedicina&quot;</span>,</a>
<a class="sourceLine" id="cb2-19" data-line-number="19">                        <span class="st">&quot;Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting (The SHARP-P Study)&quot;</span>,</a>
<a class="sourceLine" id="cb2-20" data-line-number="20">                        <span class="st">&quot;A Phase 1, Open-label, 3-period, Randomized, Partially Fixed Sequence, 2-way Crossover Study With A Microdose Of [11c]Pf-06427878 Administered With And Without Two Non-radioactive Doses Of Pf-06427878 To Characterize Tissue Distribution Using Positron Emission Tomography In Healthy Adult Male Subjects&quot;</span>,</a>
<a class="sourceLine" id="cb2-21" data-line-number="21">                        <span class="st">&quot;Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis&quot;</span>,</a>
<a class="sourceLine" id="cb2-22" data-line-number="22">                        <span class="st">&quot;Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1&quot;</span>,</a>
<a class="sourceLine" id="cb2-23" data-line-number="23">                        <span class="st">&quot;A Multi-Center Randomized Controlled Trial of Intramedullary Nails Versus Sliding Hip Screws in the Management of Intertrochanteric Fractures of the Hip&quot;</span>,</a>
<a class="sourceLine" id="cb2-24" data-line-number="24">                        <span class="st">&quot;Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer: A Prospective, Randomized, Open, Single Center Phase II Study&quot;</span>,</a>
<a class="sourceLine" id="cb2-25" data-line-number="25">                        <span class="st">&quot;Sodium Intake in Chronic Kidney Disease (STICK): A Randomised Controlled Trial&quot;</span>,</a>
<a class="sourceLine" id="cb2-26" data-line-number="26">                        <span class="st">&quot;A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in the Acute Exacerbation of Schizophrenia&quot;</span>,</a>
<a class="sourceLine" id="cb2-27" data-line-number="27">                        <span class="st">&quot;A Phase II Trial of Pazopanib in Patients With Metastatic Alveolar Soft Part Sarcoma&quot;</span>,</a>
<a class="sourceLine" id="cb2-28" data-line-number="28">                        <span class="st">&quot;Arimidex/Faslodex/Iressa Study: A Phase II Trial of Primary Systemic Therapy Using a Combination of Arimidex, Faslodex and Iressa (Gefitinib) in Postmenopausal Women With Hormone Receptor Positive Breast Cancer&quot;</span>,</a>
<a class="sourceLine" id="cb2-29" data-line-number="29">                        <span class="st">&quot;Comparison of the Long-term Effects on Mortality and Cardiovascular Morbidity of Percutaneous Coronary Intervention With Drug-eluting Stent Versus Bare-metal Stent. Randomized, Five-year Prospective, Multicenter Clinical Trial&quot;</span>,</a>
<a class="sourceLine" id="cb2-30" data-line-number="30">                        <span class="st">&quot;A Prospective, Post-market, Multi-center Comparative Study of the Efficacy of Flex Intramedullary(IM) Rod in Terms of Range of Motion (ROM) Improvement.&quot;</span>,</a>
<a class="sourceLine" id="cb2-31" data-line-number="31">                        <span class="st">&quot;Does Prescriptive Treatment of the Hips Improve Outcomes in Patients With Low Back Pain? A Randomized Controlled Trial&quot;</span>,</a>
<a class="sourceLine" id="cb2-32" data-line-number="32">                        <span class="st">&quot;Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation&quot;</span>,</a>
<a class="sourceLine" id="cb2-33" data-line-number="33">                        <span class="st">&quot;Protocol to Obtain Blood Samples for Leukemia Research&quot;</span>,</a>
<a class="sourceLine" id="cb2-34" data-line-number="34">                        <span class="st">&quot;Assessing Inherited Markers of Metabolic Syndrome in the Young&quot;</span>,</a>
<a class="sourceLine" id="cb2-35" data-line-number="35">                        <span class="st">&quot;Structural Hinders to and Promoters of Good Maternal Care in Rural China&quot;</span>,</a>
<a class="sourceLine" id="cb2-36" data-line-number="36">                        <span class="st">&quot;A Phase II Study of Bevacizumab With Docetaxel and Capecitabine in the Neoadjuvant Setting for Breast Cancer Patients&quot;</span>,</a>
<a class="sourceLine" id="cb2-37" data-line-number="37">                        <span class="st">&quot;A 6wk Open-Label, Randomised, Multicentre, Phase IIIb, Parallel Group Study to Compare the Safety &amp; Efficacy of Rosuvastatin 40mg in Comb.With Ezetimibe 10mg in Subjects With Hypercholesterolaemia &amp; CHD or Atherosclerosis or a CHD Risk Equiv. (10 yr Risk Score &gt;20%).&quot;</span>,</a>
<a class="sourceLine" id="cb2-38" data-line-number="38">                        <span class="st">&quot;The Effect of Bread Fortification With Phosphorus and Lysine on Postprandial Glycaemia and Thermogenesis&quot;</span>,</a>
<a class="sourceLine" id="cb2-39" data-line-number="39">                        <span class="st">&quot;Comparison of Ferrous Sulfate, Polymaltose Complex and Iron-zinc in Iron Deficiency Anemia&quot;</span>,</a>
<a class="sourceLine" id="cb2-40" data-line-number="40">                        <span class="st">&quot;Clinical Effects of Adjunctive Local Sodium Hypochlorite Gel in Minimally Invasive Non Surgical Debridement (MINSD) of Periodontal Pockets. A 6-month Randomized Controlled Clinical Trial&quot;</span>,</a>
<a class="sourceLine" id="cb2-41" data-line-number="41">                        <span class="st">&quot;An Open-Label, Multicenter, Multinational Study to Assess the Safety,Tolerability and Pharmacokinetics of Aerosolized Amikacin Delivered Via the Pulmonary Drug Delivery System (NKTR-061) in Intubated and Mechanically- Ventilated Patients With Nosocomial Pneumonia&quot;</span>,</a>
<a class="sourceLine" id="cb2-42" data-line-number="42">                        <span class="st">&quot;Role of Canagliflozin on Gene Expression and Function of CD34+ Endothelial Progenitor Cells and Renal Function in Patients With Type 2 Diabetes&quot;</span>,</a>
<a class="sourceLine" id="cb2-43" data-line-number="43">                        <span class="st">&quot;COMPARING THE OUTCOME IN PATIENTS OF ACUTE PANCREATITIS, WITH AND WITHOUT PROPHYLACTIC ANTIBIOTICS.&quot;</span>,</a>
<a class="sourceLine" id="cb2-44" data-line-number="44">                        <span class="st">&quot;Caelyx(R) in Breast Cancer in the Elderly. Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer.&quot;</span>,</a>
<a class="sourceLine" id="cb2-45" data-line-number="45">                        <span class="st">&quot;A Single Arm, Open Label, Perspective Study to Determine the Efficacy and Safety of Icotinib Combine Cryotherapy for Advanced NSCLC Patients&quot;</span>,</a>
<a class="sourceLine" id="cb2-46" data-line-number="46">                        <span class="st">&quot;Manual Lymphatic Drainage in Women Undergone to Thigh Lifting After Bariatric Surgery&quot;</span>,</a>
<a class="sourceLine" id="cb2-47" data-line-number="47">                        <span class="st">&quot;Evaluation of Limb-Girdle Muscular Dystrophy&quot;</span>,</a>
<a class="sourceLine" id="cb2-48" data-line-number="48">                        <span class="st">&quot;A Phase I-II Trial of Gleevec (Imatinib Mesylate) in Combination With Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia (CLL) Patients&quot;</span>,</a>
<a class="sourceLine" id="cb2-49" data-line-number="49">                        <span class="st">&quot;Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates: A Randomized, Double-Blind, Placebo-Controlled Trial&quot;</span>,</a>
<a class="sourceLine" id="cb2-50" data-line-number="50">                        <span class="st">&quot;Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Crying, Intestinal Microbiota, and Intestinal Inflammation in Infants With Colic&quot;</span>,</a>
<a class="sourceLine" id="cb2-51" data-line-number="51">                        <span class="st">&quot;Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection&quot;</span>,</a>
<a class="sourceLine" id="cb2-52" data-line-number="52">                        <span class="st">&quot;A Randomized, Double-blind, Repeat Dose, Two Period Crossover Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Inhaled Fluticasone Furoate/Vilanterol 100/25 Micrograms in Children Aged 5 to 11 Years With Persistent Asthma&quot;</span>,</a>
<a class="sourceLine" id="cb2-53" data-line-number="53">                        <span class="st">&quot;The 'Concept' of Parametria: a Proposed Classification of Parametrectomy for the Treatment of Deep Infiltrating Endometriosis. A Prospective, Clinical Trial&quot;</span></a>
<a class="sourceLine" id="cb2-54" data-line-number="54">)</a></code></pre></div>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb3-1" data-line-number="1">sample_strings_words &lt;-</a>
<a class="sourceLine" id="cb3-2" data-line-number="2"><span class="kw">process_words</span>(<span class="dt">data =</span> sample_strings,</a>
<a class="sourceLine" id="cb3-3" data-line-number="3">              <span class="dt">concept_col =</span> official_title)</a>
<a class="sourceLine" id="cb3-4" data-line-number="4"><span class="co">#&gt; Joining, by = &quot;official_title&quot;</span></a>
<a class="sourceLine" id="cb3-5" data-line-number="5">sample_strings_words</a>
<a class="sourceLine" id="cb3-6" data-line-number="6"><span class="co">#&gt; # A tibble: 652 x 2</span></a>
<a class="sourceLine" id="cb3-7" data-line-number="7"><span class="co">#&gt;    official_title                                           `official_title Worâ€¦</span></a>
<a class="sourceLine" id="cb3-8" data-line-number="8"><span class="co">#&gt;    &lt;chr&gt;                                                    &lt;chr&gt;               </span></a>
<a class="sourceLine" id="cb3-9" data-line-number="9"><span class="co">#&gt;  1 Clinical Performance of Existing Wearers of Avaira Spheâ€¦ Clinical            </span></a>
<a class="sourceLine" id="cb3-10" data-line-number="10"><span class="co">#&gt;  2 Clinical Performance of Existing Wearers of Avaira Spheâ€¦ Performance         </span></a>
<a class="sourceLine" id="cb3-11" data-line-number="11"><span class="co">#&gt;  3 Clinical Performance of Existing Wearers of Avaira Spheâ€¦ Existing            </span></a>
<a class="sourceLine" id="cb3-12" data-line-number="12"><span class="co">#&gt;  4 Clinical Performance of Existing Wearers of Avaira Spheâ€¦ Wearers             </span></a>
<a class="sourceLine" id="cb3-13" data-line-number="13"><span class="co">#&gt;  5 Clinical Performance of Existing Wearers of Avaira Spheâ€¦ Avaira              </span></a>
<a class="sourceLine" id="cb3-14" data-line-number="14"><span class="co">#&gt;  6 Clinical Performance of Existing Wearers of Avaira Spheâ€¦ Sphere              </span></a>
<a class="sourceLine" id="cb3-15" data-line-number="15"><span class="co">#&gt;  7 Clinical Performance of Existing Wearers of Avaira Spheâ€¦ Enfilcon            </span></a>
<a class="sourceLine" id="cb3-16" data-line-number="16"><span class="co">#&gt;  8 Clinical Performance of Existing Wearers of Avaira Spheâ€¦ Following           </span></a>
<a class="sourceLine" id="cb3-17" data-line-number="17"><span class="co">#&gt;  9 Clinical Performance of Existing Wearers of Avaira Spheâ€¦ Refit               </span></a>
<a class="sourceLine" id="cb3-18" data-line-number="18"><span class="co">#&gt; 10 Clinical Performance of Existing Wearers of Avaira Spheâ€¦ With                </span></a>
<a class="sourceLine" id="cb3-19" data-line-number="19"><span class="co">#&gt; # â€¦ with 642 more rows</span></a></code></pre></div>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb4-1" data-line-number="1"><span class="kw">process_unique_words</span>(<span class="dt">data =</span> sample_strings_words,</a>
<a class="sourceLine" id="cb4-2" data-line-number="2">                     <span class="dt">words_col =</span> <span class="st">`</span><span class="dt">official_title Words</span><span class="st">`</span>)</a>
<a class="sourceLine" id="cb4-3" data-line-number="3"><span class="co">#&gt; Joining, by = &quot;official_title Words&quot;</span></a>
<a class="sourceLine" id="cb4-4" data-line-number="4"><span class="co">#&gt; # A tibble: 652 x 3</span></a>
<a class="sourceLine" id="cb4-5" data-line-number="5"><span class="co">#&gt;    official_title                        `official_title Wâ€¦ `official_title Worâ€¦</span></a>
<a class="sourceLine" id="cb4-6" data-line-number="6"><span class="co">#&gt;    &lt;chr&gt;                                 &lt;chr&gt;              &lt;chr&gt;               </span></a>
<a class="sourceLine" id="cb4-7" data-line-number="7"><span class="co">#&gt;  1 Clinical Performance of Existing Weaâ€¦ Clinical           &lt;NA&gt;                </span></a>
<a class="sourceLine" id="cb4-8" data-line-number="8"><span class="co">#&gt;  2 Clinical Performance of Existing Weaâ€¦ Performance        Performance         </span></a>
<a class="sourceLine" id="cb4-9" data-line-number="9"><span class="co">#&gt;  3 Clinical Performance of Existing Weaâ€¦ Existing           Existing            </span></a>
<a class="sourceLine" id="cb4-10" data-line-number="10"><span class="co">#&gt;  4 Clinical Performance of Existing Weaâ€¦ Wearers            Wearers             </span></a>
<a class="sourceLine" id="cb4-11" data-line-number="11"><span class="co">#&gt;  5 Clinical Performance of Existing Weaâ€¦ Avaira             Avaira              </span></a>
<a class="sourceLine" id="cb4-12" data-line-number="12"><span class="co">#&gt;  6 Clinical Performance of Existing Weaâ€¦ Sphere             &lt;NA&gt;                </span></a>
<a class="sourceLine" id="cb4-13" data-line-number="13"><span class="co">#&gt;  7 Clinical Performance of Existing Weaâ€¦ Enfilcon           Enfilcon            </span></a>
<a class="sourceLine" id="cb4-14" data-line-number="14"><span class="co">#&gt;  8 Clinical Performance of Existing Weaâ€¦ Following          &lt;NA&gt;                </span></a>
<a class="sourceLine" id="cb4-15" data-line-number="15"><span class="co">#&gt;  9 Clinical Performance of Existing Weaâ€¦ Refit              Refit               </span></a>
<a class="sourceLine" id="cb4-16" data-line-number="16"><span class="co">#&gt; 10 Clinical Performance of Existing Weaâ€¦ With               &lt;NA&gt;                </span></a>
<a class="sourceLine" id="cb4-17" data-line-number="17"><span class="co">#&gt; # â€¦ with 642 more rows</span></a></code></pre></div>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" data-line-number="1"><span class="kw">process_longest_words</span>(<span class="dt">data =</span> sample_strings_words,</a>
<a class="sourceLine" id="cb5-2" data-line-number="2">                      <span class="dt">concept_col =</span> official_title,</a>
<a class="sourceLine" id="cb5-3" data-line-number="3">                      <span class="dt">words_col =</span> <span class="st">`</span><span class="dt">official_title Words</span><span class="st">`</span>)</a>
<a class="sourceLine" id="cb5-4" data-line-number="4"><span class="co">#&gt; Joining, by = &quot;official_title&quot;</span></a>
<a class="sourceLine" id="cb5-5" data-line-number="5"><span class="co">#&gt; # A tibble: 889 x 3</span></a>
<a class="sourceLine" id="cb5-6" data-line-number="6"><span class="co">#&gt;    official_title                        `official_title Wâ€¦ `official_title Lonâ€¦</span></a>
<a class="sourceLine" id="cb5-7" data-line-number="7"><span class="co">#&gt;    &lt;chr&gt;                                 &lt;chr&gt;              &lt;chr&gt;               </span></a>
<a class="sourceLine" id="cb5-8" data-line-number="8"><span class="co">#&gt;  1 Clinical Performance of Existing Weaâ€¦ Clinical           Performance         </span></a>
<a class="sourceLine" id="cb5-9" data-line-number="9"><span class="co">#&gt;  2 Clinical Performance of Existing Weaâ€¦ Performance        Performance         </span></a>
<a class="sourceLine" id="cb5-10" data-line-number="10"><span class="co">#&gt;  3 Clinical Performance of Existing Weaâ€¦ Existing           Performance         </span></a>
<a class="sourceLine" id="cb5-11" data-line-number="11"><span class="co">#&gt;  4 Clinical Performance of Existing Weaâ€¦ Wearers            Performance         </span></a>
<a class="sourceLine" id="cb5-12" data-line-number="12"><span class="co">#&gt;  5 Clinical Performance of Existing Weaâ€¦ Avaira             Performance         </span></a>
<a class="sourceLine" id="cb5-13" data-line-number="13"><span class="co">#&gt;  6 Clinical Performance of Existing Weaâ€¦ Sphere             Performance         </span></a>
<a class="sourceLine" id="cb5-14" data-line-number="14"><span class="co">#&gt;  7 Clinical Performance of Existing Weaâ€¦ Enfilcon           Performance         </span></a>
<a class="sourceLine" id="cb5-15" data-line-number="15"><span class="co">#&gt;  8 Clinical Performance of Existing Weaâ€¦ Following          Performance         </span></a>
<a class="sourceLine" id="cb5-16" data-line-number="16"><span class="co">#&gt;  9 Clinical Performance of Existing Weaâ€¦ Refit              Performance         </span></a>
<a class="sourceLine" id="cb5-17" data-line-number="17"><span class="co">#&gt; 10 Clinical Performance of Existing Weaâ€¦ With               Performance         </span></a>
<a class="sourceLine" id="cb5-18" data-line-number="18"><span class="co">#&gt; # â€¦ with 879 more rows</span></a></code></pre></div>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" data-line-number="1"><span class="kw">process_first_parentheses</span>(<span class="dt">data =</span> sample_strings,</a>
<a class="sourceLine" id="cb6-2" data-line-number="2">              <span class="dt">concept_col =</span> official_title)</a>
<a class="sourceLine" id="cb6-3" data-line-number="3"><span class="co">#&gt; Joining, by = &quot;official_title&quot;</span></a>
<a class="sourceLine" id="cb6-4" data-line-number="4"><span class="co">#&gt; # A tibble: 50 x 4</span></a>
<a class="sourceLine" id="cb6-5" data-line-number="5"><span class="co">#&gt;    official_title     `official_title Froâ€¦ `official_title â€¦ `official_title Beâ€¦</span></a>
<a class="sourceLine" id="cb6-6" data-line-number="6"><span class="co">#&gt;    &lt;chr&gt;              &lt;chr&gt;                &lt;chr&gt;             &lt;chr&gt;              </span></a>
<a class="sourceLine" id="cb6-7" data-line-number="7"><span class="co">#&gt;  1 Clinical Performaâ€¦ Clinical Performancâ€¦ Enfilcon A        &quot;Following a Refitâ€¦</span></a>
<a class="sourceLine" id="cb6-8" data-line-number="8"><span class="co">#&gt;  2 An Open-label Expâ€¦ An Open-label Exploâ€¦ 'HAE'             &quot;&quot;                 </span></a>
<a class="sourceLine" id="cb6-9" data-line-number="9"><span class="co">#&gt;  3 Molecular Signatuâ€¦ &lt;NA&gt;                 &lt;NA&gt;               &lt;NA&gt;              </span></a>
<a class="sourceLine" id="cb6-10" data-line-number="10"><span class="co">#&gt;  4 The Role of Fractâ€¦ The Role of Fractioâ€¦ RVVC              &quot;ï¼ša Study Protocoâ€¦</span></a>
<a class="sourceLine" id="cb6-11" data-line-number="11"><span class="co">#&gt;  5 Colonization, Safâ€¦ &lt;NA&gt;                 &lt;NA&gt;               &lt;NA&gt;              </span></a>
<a class="sourceLine" id="cb6-12" data-line-number="12"><span class="co">#&gt;  6 The Reduction of â€¦ The Reduction of Miâ€¦ SMART             &quot;&quot;                 </span></a>
<a class="sourceLine" id="cb6-13" data-line-number="13"><span class="co">#&gt;  7 A Randomized Openâ€¦ &lt;NA&gt;                 &lt;NA&gt;               &lt;NA&gt;              </span></a>
<a class="sourceLine" id="cb6-14" data-line-number="14"><span class="co">#&gt;  8 Pilot Study 1 of â€¦ &lt;NA&gt;                 &lt;NA&gt;               &lt;NA&gt;              </span></a>
<a class="sourceLine" id="cb6-15" data-line-number="15"><span class="co">#&gt;  9 Prophylactic Sub-â€¦ &lt;NA&gt;                 &lt;NA&gt;               &lt;NA&gt;              </span></a>
<a class="sourceLine" id="cb6-16" data-line-number="16"><span class="co">#&gt; 10 A Phase 1, Randomâ€¦ &lt;NA&gt;                 &lt;NA&gt;               &lt;NA&gt;              </span></a>
<a class="sourceLine" id="cb6-17" data-line-number="17"><span class="co">#&gt; # â€¦ with 40 more rows</span></a></code></pre></div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
